Anticorps Monoclonal anti-ZG16

ZG16 Monoclonal Antibody for WB, IHC, IF-P, IF-Fro, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, porc, rat, souris

Applications

WB, IHC, IF-P, IF-Fro, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1A7B9

N° de cat : 67389-1-PBS

Synonymes

1A7B9, FLJ43571, FLJ92276, hZG16, JCLN



Informations sur le produit

67389-1-PBS cible ZG16 dans les applications de WB, IHC, IF-P, IF-Fro, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc, rat, souris

Réactivité Humain, porc, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène ZG16 Protéine recombinante Ag11332
Nom complet zymogen granule protein 16 homolog (rat)
Masse moléculaire calculée 167 aa, 18 kDa
Poids moléculaire observé 16 kDa
Numéro d’acquisition GenBankBC029149
Symbole du gène ZG16
Identification du gène (NCBI) 653808
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Zymogen granule protein 16 (ZG16) has a Jacalin-like lectin domain, which is mainly expressed by mucus-secreting cells, including goblet cells in the intestine. It's reported that ZG16 expression was significantly decreased in colorectal cancer compared to normal tissue. ZG16 gene expression and copy number variations (CNV) were associated with multiple molecular and clinicopathological features of CRC including MSI, MLH1 silencing and so on. It's found that ZG16 is negatively correlated with lymphatic invasive and distant metastasis. Besides, overexpression of ZG16 blocks PD-L1 expression in colorectal cancer, and promotes NK cells survival and proliferation. Very importantly, ZG16 suppresses colorectal tumor growth via the immune system. (PMID: 33360840, 21893569)

{{ptg:RelatedPrimaryAntibodies}}